PROFESSIONAL EDITION

The largest community of pharma leaders

Medical Devices

      GE Healthcare Acquires Zionexa; Molecular Imaging Agent Aims to Enable More Targeted Treatment for Metastatic Breast Cancer Patients

      MARLBOROUGH, Mass.--(BUSINESS WIRE)--GE Healthcare today announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable more personalized...

      Sommetrics Receives IDE Approval From the FDA to Begin SUPRA Trial of aerSleep II for Treating Sleep Apnea

      VISTA, Calif.--(BUSINESS WIRE)--Sommetrics is pleased to announce US Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) application to conduct a...

      ZAP Surgical Announces Future Installation of Novel Non-Invasive Brain Tumor Treatment System in Munich, Germany

      SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc. today announced the upcoming installation of its advanced ZAP-X® Gyroscopic Radiosurgery® platform at the European CyberKnife® Center...

      AgNovos Healthcare Receives Investigational Device Exemption (IDE) for Breakthrough Spine Device

      NEW YORK--(BUSINESS WIRE)--AgNovos Healthcare, a developer of medical technology products leveraging regenerative medicine to treat the local effects of bone disease, announced today that...

      Recent Articles

      Post